摘要
目的:评价银质针导热疗法治疗肌筋膜疼痛综合征的临床安全性。方法:采用随机单盲方法观察378例肌筋膜疼痛综合征患者进行银质针导热疗法治疗前后血、尿、便常规、肝肾功能、心肌酶及心电图的变化;针刺前1h、局部麻醉即刻、局部麻醉后10min、针刺即刻和针刺治疗后1h动态检测心率、呼吸、血压、血氧饱和度变化。结果:银质针治疗前后患者血常规、尿常规、便常规、肝肾功能、心肌酶检测结果无显著性差异(P>0.05);银质针导热疗法前、中、后动态检测心率、呼吸、血压、血氧饱和度变化结果显示,心率、呼吸、血压、血氧饱和度无明显异常变化。结论:经安全性系列研究证明:银质针导热疗法治疗肌筋膜疼痛综合征是安全的,使用于老年人和稳定期心脏病患者。
Objective： To evaluate the safety of silver needle thermo-conduction therapy for myofascialgia syndrome. Method： Three hundred and seventy-eight patients with myofascialgia syndrome were monitored before, during and after silver needle thermo-conduction treatment. The data concerned were recorded and analysed before and after treatment： blood, urine and feces routine examination, hepatic and renal functions, myoeardiase measurement and electrocardiogram： and the indexes changes of heart beating rates, respiration, blood pressure and oxygen saturation of blood were monitored dynamically before, during and after silver needle thermo-conduction therapy and local anesthesia. Result： Before and after treatment, the results of blood, urine and feces routine examination, hepatic and renal functions and myocardiase were normal without obvious difference （P〉0.05）. No obvious abnormal change was found in the rest above-mentioned parameters during the monitoring. Conclusion： The silver needle thermo-conduction therapy for myofascialgia syndrome is safe and reliable. The therapy is also suitable for the elderly and the patients with heart diseases in stable stage.
出处
《中国康复医学杂志》
CAS
CSCD
北大核心
2010年第1期39-41,共3页
Chinese Journal of Rehabilitation Medicine
关键词
肌筋膜疼痛综合征
银质针
导热疗法
安全性
myofascialgia syndrome
silver needle
thermo-eonduetion therapy
safety
